NASDAQ · STOCK
Encompass Health
$111.04
52W $92.77 – $127.99
56/100
$11.02B
18.3
0.60
Is EHC Bullish or Bearish?
Mixed.
Innellis AI committee rates Encompass Health (EHC) Watch with a composite score of 56/100
, based on 6 analysts with 83% agreement.
Last updated July 31, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +4.45 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -15.55 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
Some positive signals exist — 4 consecutive earnings beats -- consistent execution — but they are not yet strong enough to justify a Buy. The committee is monitoring for confirmation.
Bull & Bear Case
Bull Case
- ROE of 25.4% shows genuine earnings power backing the valuation — Value
- 4 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- Price-to-book of 4.4x prices in significant intangible value — Value
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of July 31, 2026
Overall Committee Score
56/100
Agreement
83%
Analysts
6
Conviction
High
Sector Rank
Top 51%
of 93 Healthcare peers
Value Analyst
neutral
55
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 25.4% shows genuine earnings power backing the valuation
− Price-to-book of 4.4x prices in significant intangible value
Growth Analyst
bullish
60
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ 4 consecutive earnings beats -- consistent execution
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst
neutral
58
/ 100 · High confidence
Mixed or range-bound price action
+ Price structure making higher highs and higher lows
− MACD histogram negative -- bearish momentum
Macro Analyst
neutral
58
/ 100 · Moderate confidence
Macro backdrop is mixed or neutral -- not a strong tailwind or headwind either way
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
neutral
58
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2744.14)
Investment Thesis Evolution
Committee score moved marginally from 58.5 to 55.5.
- Conviction strengthened -- analysts aligned more closely.
- Committee agreement increased sharply from 50% to 83%.
- New bearish signals: 3 appeared.
- Bullish support removed: 1 signal(s) disappeared.
- New bullish signals: 1 appeared.
- Bearish pressure eased: 2 signal(s) disappeared.
- Analyst(s) changed stance: Macro Analyst, Technical Analyst.
Analyst-level changes:
- Macro Analyst: stance bullish->neutral; score 65->58 (-8); +1 bullish signal(s).
- Portfolio Manager: +2 bearish signal(s).
- Technical Analyst: stance bullish->neutral; score 68->58 (-10); +1 bearish signal(s).
Comparing 2026-07-30 to 2026-07-31 (1 day apart).
Technical Analysis
RSI (14)
47.3
Neutral
MACD Histogram
-0.247
Bearish Momentum
Trend Direction
Uptrend
Weekly: Sideways
Market Structure
Mixed
Support
$107.86
Resistance
$115.16
Bollinger %B
0.46
Inside Bands
Price vs Moving Averages
EMA 9
$112.14
Below
EMA 21
$110.44
Above
EMA 50
$107.61
Above
EMA 200
$106.91
Above
Fundamental Analysis
Valuation
81
Growth
72
Profitability
1
Financial Health
50
Cash Flow
36
Valuation
P/E Ratio
18.3×
P/B Ratio
4.37×
PEG Ratio
0.77
Dividend Yield
0.01%
52W High
$127.99
52W Low
$92.77
Quality & Growth
ROE
23.2%
ROA
8.0%
Gross Margin
58.8%
Operating Margin
17.9%
Revenue Growth YoY
—
Debt / Equity
1.11
AI Fundamental Assessment
P/E ratio of 18.3 (inexpensive relative to a 15-40x range); Price-to-book of 4.4x; PEG ratio of 0.8 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 0.2%; Return on assets of 0.1%; Net margin of 0.1%; Gross margin of 0.6%; Current ratio of 1.17 (tight short-term liquidity); Debt-to-equity of 1.11; Free cash flow margin of 0.4% (thin cash generation); Free cash flow per share is positive (4.68); Most recent quarter beat estimates by 5.8%; 4 consecutive earnings beats; EPS growth decelerating (+18.7% -> +9.6% QoQ); Analyst estimates rising over recent quarters
Get the Full EHC Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →